Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads

被引:0
作者
Jagrati Jain
Surendra K. Jain
Larry A. Walker
Babu L. Tekwani
机构
[1] University of Mississippi,National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy
[2] University of Mississippi,Department of BioMolecular Sciences, Division of Pharmacology, School of Pharmacy
来源
BMC Pharmacology and Toxicology | / 18卷
关键词
Malaria; arum; Ubiquitine; Proteasome; Ubiquitine E3 ligase; Antimalarial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 124 条
[1]  
Sinha S(2014)Challenges of drug-resistant malaria Parasite 21 61-30
[2]  
Medhi B(2011)Unraveling the ubiquitome of the human malaria parasite J Biol Chem 286 40320-50
[3]  
Sehgal R(2012)Characterization of the ubiquitylating components of the human malaria parasite’s protein degradation pathway PLoS One 7 e43477-53
[4]  
Ponts N(2010)Identification of a primary target of thalidomide teratogenicity Science 327 1345-42
[5]  
Saraf A(2014)Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide Nature 512 49-95
[6]  
Chung DW(2010)Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase Nat Biotechnol 28 738-41
[7]  
Harris A(2010)Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage Cancer Cell 18 382-62
[8]  
Prudhomme J(2009)Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy Annu Rev Pharmacol Toxicol 49 223-33
[9]  
Washburn MP(2006)Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy J Med Chem 49 3759-50
[10]  
Florens L(2007)Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening Antimicrob Agents Chemother 51 1926-90